ELAN
Elanco Animal Health IncCompany with tickers: ELAN
CIK
1739104
CUSIP
28414H103
Shares Outstanding
499,449,583
13F Activity (30d)
240 filings
235 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,371,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | $785,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | — | ||||
| Research & Development | $97,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | — | ||||
| Net Income | $57,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $0.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $0.11 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |